FRIDAY, JUNE 9th | ||||
Reaching an International Consensus on Standardizing Continuous Glucose Monitoring (CGM) Outcomes―Aligning Clinicians, Researchers, Patients, and Regulators
Simon R. Heller, FRCP, DM
|
||||
SATURDAY, JUNE 10th | ||||
GLP-1s and SGLT2s—To Do or Not to Do in Type 1 Diabetes Mellitus?
Thomas F. Dejgaard, MD
|
||||
SUNDAY, JUNE 11th | ||||
Joint ADA/ASN Symposium—Effects of New Diabetic Treatments on Diabetic Kidney Disease
Katherine R. Tuttle, MD, FACP, FASN, FNKF
|
||||
MONDAY, JUNE 12th | ||||
Hepatic Lipid and Glucose Metabolism
Michael Roden, MD – Director
|
||||
New Insights into Prevention and Treatment of Hypoglycemia
Candace Reno, PhD
|
||||
TUESDAY, JUNE 13th | ||||
Take-home Messages from 2017 ADA Scientific Sessions
Jane Reusch, MD
|
||||
FRIDAY, JUNE 22 | ||||
Real-World Evidence in Diabetes
Stewart B. Harris, MD
|
||||
SATURDAY, JUNE 23 | ||||
Reframing Exercise―The Surprising Science behind Motivating Patients to Be More Physically Active
Michelle Segar, PhD, MPH
|
||||
ADA Diabetes Care Symposium―Using Continuous Glucose Monitoring and Smart Devices to Control Glucose when It Matters Most
Jennifer Sherr, MD, PhD
|
||||
SUNDAY, JUNE 24 | ||||
Update on Type 2 Diabetes Clinical Trials
Richard E. Pratley, MD
|
||||
The Veterans Affairs Diabetes Trial (VADT) at 15 Years
Peter Reaven MD, Division of Endocrinology and Metabolism, Department of Medicine (CS-111E)
|
||||
MONDAY, JUNE 25 | ||||
Update on Hypoglycemia
Prof. Simon Heller
|
||||
Clinical Trials for Type 1 Diabetes—Current, Emerging, and Novel
Robert Ratner, MD Professor of Medicine, Georgetown University School of Medicine
|
||||
TUESDAY, JUNE 26 | ||||
Insulin Therapy—To the Future and Back
Carol Wysham, MD
|
||||
Management of Hyperglycemia in Type 2 Diabetes—Draft ADA/EASD Consensus Report 2018
Deborah Jane Wexler, MD
|
||||
JUNE 10TH, 2019 | ||||
Carolina, results from a major clinical trial
Steven Khan, MD
|
||||
JUNE 8TH, 2019 | ||||
Joint ADA/ACC Mini-Symposium – Cardiovascular Disease in Patients with Diabetes?
Darren McGuire, MD
|
||||
JUNE 9TH, 2019 | ||||
Once-Weekly Dulaglutide and Major Cardiovascular Events—Results of the REWIND Trial
Vivian Fonseca, MD
|
||||
JUNE 11TH, 2019 | ||||
Carmelina, results from a major clinical trial
Steven Khan, MD
|
||||